FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Heritage Pharmaceuticals Cidofovir Injection 375mg/5mL Recall

Cidofovir Injection 375mg/5mL (75mg/mL) vial injection

Heritage Pharmaceuticals, Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Jan 16, 2019
Recall ID
D-0352-2019
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled Cidofovir Injection 375mg/5mL starting Jan 2, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0352-2019 on Jan 16, 2019. Reason: Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle

Product description

Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31

Lot numbers, UPCs & expiration codes

Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0352-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 2, 2019
FDA report date
Jan 16, 2019
Quantity
5,060 units
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0352-2019, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
81896
Address
1 Tower Center Blvd Ste 1700
Code information
Lot #: VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020
Postal code
08816-1145
Report date
Jan 16, 2019
Product type
Drugs
Recall number
D-0352-2019
Classification
Class II
Recalling firm
Heritage Pharmaceuticals, Inc.
Product quantity
5,060 units
Termination date
Feb 19, 2021
Reason for recall
Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31
Distribution pattern
Nationwide
Recall initiation date
Jan 2, 2019
Initial firm notification
Letter
Center classification date
Jan 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0352-2019, published Jan 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls